ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2919

The Novel Rheumatoid Arthritis (RA) Risk Gene, LBH, Is Regulated By TGFß and PDGF and Modulates Cell Growth in Fibroblast-like Synoviocytes

Anna-Karin Ekwall1, Deepa Hammaker2, John W. Whitaker3, William Bugbee4, Wei Wang5 and Gary S. Firestein6, 1Medicine, UC San Diego, La Jolla, CA, 2Medicine, University of California San Diego, La Jolla, CA, 3860 island ave, UCSD, San Diego, CA, 4Orthopaedics, Scripps Clinic, La Jolla, CA, 5Chemistry, UCSD, La Jolla, CA, 6Division of Rheumatology, Allergy and Immunology, University of California at San Diego School of Medicine, La Jolla, CA

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Epigenetics, Fibroblasts, methylation, rheumatoid arthritis (RA) and transcriptional regulation

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Human Etiology and Pathogenesis II: Citrullination, Autoantibodies and Genes

Session Type: Abstract Submissions (ACR)

Background/Purpose: RA fibroblast-like synoviocytes (FLS) display an aggressive phenotype, such as increased cytokine production and cell growth. Currently no therapeutics specifically target FLS. To this end, we have taken an unbiased integrative omics approach to identify therapeutic candidate gene by combining three different genome-wide assays: (i) GWAS in RA, (ii) differentially expressed genes in RA vs. osteoarthritis (OA) FLS and, (iii) differential DNA methylation in RA vs. OA FLS. We identified and characterized one gene present in all three databases, namely limb bud and heart development (LBH). LBH is a conserved putative protein with largely unknown functions. 

Methods: FLS cultures were established from RA and OA synovial tissues from joint replacement surgery. Gene expression was measured by qPCR. LBH gene expression was silenced using siRNA (mean 91% decrease) or over-expressed (mean 13 fold increase) using an LBH expression vector. Differentially expressed genes of 4 RA FLS lines with modified lbh expression were determined by microarray. The affected pathways were identifed using Ingenuity Pathway Analysis. Effects of modified lbhgene expression were assessed by cell migration (scratch-wound assay), cell growth (MTT), apoptosis (caspase 3/7 activity) and TNF-stimulated gene expression.

Results: LBH is constitutively expressed in RA FLS as determined by qPCR. TGFß stimulation (1 ng/ml, 18 hr) significantly increased LBH mRNA by 5.0±0.4 fold (P=0.02) and PDGF-BB (0.1 ng/ml,12 hr) significantly decreased LBH mRNA expression by 5.7±1.7 fold (P=0.04). Stimulating FLS with TNF, Wnt1, Wnt3a or Wnt 5a had no effect on LBH gene expression. LBH was then knocked down using siRNA, with no effects on cell migration or TNF-induced MMP3 or IL-6 expression. To determine potential functions, microarrays were performed using LBH-deficient FLS. Pathway analysis of gene expression profiles in LBHlow compared to control FLS identified “Cellular growth and proliferation” as the most significantly enriched pathway. Therefore, we performed cell growth assays.  LBH-deficiency increased FLS proliferation by 92±15% (p=0.025). Conversely, LBH-overexpressing FLS significantly inhibited cell growth by 62±10% (P=0.018). LBH did not alter apoptosis.

Conclusion: We identified LBH as a candidate gene for RA by integrating multiple omics datasets. Microarray experiments focused our attention on cell growth as a potential LBH-regulated function, and this was confirmed using functional assays. Furthermore, the gene is highly regulated by growth factors that modulate the cell cycle. The data suggest that LBH contributes to synovial intimal hyperplasia and joint damage in RA.


Disclosure:

A. K. Ekwall,
None;

D. Hammaker,
None;

J. W. Whitaker,
None;

W. Bugbee,
None;

W. Wang,
None;

G. S. Firestein,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-novel-rheumatoid-arthritis-ra-risk-gene-lbh-is-regulated-by-tgfs-and-pdgf-and-modulates-cell-growth-in-fibroblast-like-synoviocytes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology